Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.

doi:10.1097/MCG.0b013e3182a4711d

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.

Journal of clinical gastroenterology - 1 Feb 2014

Yim Sun Young, Um Soon Ho, Jung Jin Young, Seo Yeon Seok, Yim Hyung Joon, Ryu Ho Sang, Chun Hoon Jai, Jeen Yoon Tae, Kim Chang Duck, Keum Bora, Lee Hong Sik

Abstract excerpt

BACKGROUND: Inactive and active phases of hepatitis B e antigen-negative chronic hepatitis B virus (HBV) infection are diagnosed by serum HBV DNA levels, with cutoff at 2000 IU/mL. However, it is difficult to distinguish inactive carriers at a single time point because HBV DNA levels can transiently decrease to <2000 IU/mL even in noninactive carriers. GOALS: We aimed to establish the role of serum hepatitis B...

Topics

Adult
Age Factors
Aged
Alanine Transaminase
Area Under Curve
Carrier State
DNA, Viral
Female
Follow-Up Studies
Genotype
Hepatitis B Surface Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Hepatitis B e Antigens

Hepatitis B virus

Hepatitis B, Chronic

Humans

Male

Middle Aged

ROC Curve

Source

Open in PubMed

Identifiers

PMID: 24045280
DOI: 10.1097/MCG.0b013e3182a4711d

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.PMID 24045280Read ↗

Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype.Semantic proximity Read ↗

Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B.Semantic proximity Read ↗

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Semantic proximity Read ↗

Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection.Semantic proximity Read ↗

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Semantic proximity Read ↗

Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers.Semantic proximity Read ↗

Determination of hepatitis B phenotype using biochemical and serological markers.Semantic proximity Read ↗

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriersSemantic proximity Read ↗

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.Semantic proximity Read ↗

Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.